project id: TCGA-SKCM; case submitter id: TCGA-EE-A2GN; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 8.7; age at index: 67; days to birth: -24683; days to death: 3106; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1936; age at diagnosis: 24683; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2767.0; icd 10 code: C49.3; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: Yes; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of thorax; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2003; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 2766; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-EE-A2GN-06A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 1.0; percent necrosis: 1.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 24.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0;